Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine and Atomoxetine in Neurogenic Orthostatic Hypotension
NCT03350659Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atomoxetine in Neurogenic Orthostatic Hypotension (nOH), sponsored by Seoul National University Hospital. Started Jan 2018; status: completed.
02
Drugs
atomoxetine
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on NCT03350659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03350659.